EORTC 10968: A phase I clinical and pharamacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer
| Data(s) |
2002
|
|---|---|
| Resumo |
SCOPUS: ar.j info:eu-repo/semantics/published |
| Formato |
No full-text files |
| Identificador |
uri/info:doi/10.1093/annonc/mdf157 http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/84202 |
| Idioma(s) |
en |
| Fonte |
Annals of oncology, 13 (6 |
| Palavras-Chave | #Cancérologie #Sciences bio-médicales et agricoles #Breast cancer #Liposomal doxorubicin #Schedule |
| Tipo |
info:eu-repo/semantics/article info:ulb-repo/semantics/articlePeerReview info:ulb-repo/semantics/openurl/article |
